Oxalate nephropathy and intravenous vitamin C

American Journal of Kidney Diseases

Volumn 61, Issue 6, 2013, Pages 1032-1035

  Cossey, L Nicholas ^a,c   Rahim, Fahim ^b   Larsen, Christopher P ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Idaho Kidney Institute   (United States)

^c Nephropathology Associates   (United States)

Author keywords

acute kidney injury; acute renal failure; alternative medicine; ascorbic acid; lupus; Oxalate; oxalosis; systemic lupus erythematosus (SLE); traditional medicine; vitamin C

Indexed keywords

ANTINUCLEAR ANTIBODY; ASCORBIC ACID; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE; CREATININE; DOUBLE STRANDED DNA ANTIBODY; HEMOGLOBIN; METHYLPREDNISOLONE; OXALIC ACID; TAMM HORSFALL GLYCOPROTEIN;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CREATININE BLOOD LEVEL; ECHOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TUBULE; MEAN CORPUSCULAR VOLUME; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; OXALIC ACID NEPHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; URINE VOLUME;

ACUTE KIDNEY INJURY; ADMINISTRATION, INTRAVENOUS; ASCORBIC ACID; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; HYPEROXALURIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; VITAMINS;

EID: 84877920410     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.01.025     Document Type: Article

References (30)

1. Z.G. Laszik, L. Haragsim Metabolic diseases of the kidney F. Silva, Diagnostic Renal Pathology 1st ed. 2009 Cambridge University Press New York, NY 303 305
2. Harambat J, Fargue S, Bacchetta J, Acquaviva C, Cochat P. Primary hyperoxaluria [published online ahead of print June 16, 2011]. Int J Nephrol. doi:10.4061/2011/864580.
3. A.J. Chaplin Histopathological occurrence and characterization of calcium oxalate: a review J Clin Pathol 30 9 1977 800 811
4. S.H. Nasr, V.D. D'Agati, S.M. Said Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure Clin J Am Soc Nephrol 3 6 2008 1676 1683
5. Y. Ogawa, S. Takahashi, R. Kitagawa Oxalate content in common Japanese foods Acta Urol Jpn 30 3 1984 305 310
6. W. Chai, M. Liebman Oxalate content of legumes, nuts, and grain-based flours J Food Composition Analysis 18 2005 723 729
7. Oxalosis and Hyperoxaluria Foundation The oxalate content of food http://www.ohf.org/docs/Oxalate2008.pdf Accessed October 3, 2011
8. P. Jaeger, W.G. Robertson Role of dietary intake and intestinal absorption of oxalate in calcium stone formation Nephron Physiol 98 2 2004 64 71
9. S. Robijn, B. Hoppe, B.A. Vervaet, P.C. D'Haese, A. Verhulst Hyperoxaluria: a gut-kidney axis Kidney Int 80 11 2011 1146 1158
10. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
11. E. Cameron, L. Pauling Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer Proc Natl Acad Sci U S A 73 10 1976 3685 3689
12. C.F. Verkoelen, A. Verhulst Proposed mechanisms in renal tubular crystal retention Kidney Int 72 1 2007 13 18
13. F.L. Coe, J.H. Parks, J.R. Asplin The pathogenesis and treatment of kidney stones N Engl J Med 327 16 1992 1141 1152
14. S.R. Khan Renal tubular damage/dysfunction: key to the formation of kidney stones Urol Res 34 2 2006 86 91
15. J.M. Lawton, L.T. Conway, J.T. Crosson, C.L. Smith, P.A. Abraham Acute oxalate nephropathy after massive ascorbic acid administration Arch Intern Med 145 5 1985 950 951
16. K. Wong, C. Thomson, R.R. Bailey, S. McDiarmid, J. Gardner Acute oxalate nephropathy after a massive intravenous dose of vitamin C Aust N Z J Med 24 4 1994 410 411
17. Lamarche J, Nair R, Peguero A, Courville C. Vitamin C-induced oxalate nephropathy [published online ahead of print March 16, 2011]. Int J Nephrol. doi:10.4061/2011/146927.
18. S.H. Nasr, Y. Kashtanova, V. Levchuk, G.S. Markowitz Secondary oxalosis due to excess vitamin C intake Kidney Int 70 10 2006 1672
19. S. Mashour, J.F. Turner, B. Merrell Acute renal failure, oxalosis, and vitamin C supplementation Chest 118 2 2000 561 563
20. E. Cameron, L. Pauling Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer Proc Natl Acad Sci U S A 75 9 1978 4538 4542
21. S.J. Padayatty, A.Y. Sun, Q. Chen Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects PLoS ONE 5 7 2010 e11414
22. V.A. Luyckx, S. Naicker Acute kidney injury associated with the use of traditional medicines Nat Clin Pract Nephrol 4 12 2008 664 671
23. B. Hoppe An update on primary hyperoxaluria Nat Rev Nephrol 8 8 2012 467 475
24. M. Hatch, R.W. Freel Intestinal transport of an obdurate anion: oxalate Urol Res 33 1 2005 1 16
25. M. Hatch, J. Cornelius, M. Allison, H. Sidhu, A. Peck, R.W. Freel Oxalobacter sp. reduces urinary oxalate excretion promoting enteric oxalate excretion Kidney Int 69 4 2006 691 698
26. M. Allison, K. Dawson, W. Mayberry, J. Foss Oxalobacter formigenes gen. nov., sp. Nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract Arch Microbiol 141 1 1985 1 7
27. B. Hoppe, B. Beck, N. Gatter Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type I Kidney Int 70 7 2006 1305 1311
28. B. Hoppe, J.W. Groothoff, S.A. Hulton Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria Nephrol Dial Transplant 26 11 2011 3609 3615
29. D.S. Milliner, J.T. Eickholt, E.J. Bergstralh, D.M. Wilson, L.H. Smith Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria N Engl J Med 331 23 1994 1553 1558
30. S. Habbig, B.B. Beck, B. Hoppe Nephrocalcinosis and urolithiasis in children Kidney Int 80 12 2011 1278 1291